My mentor and friend, Vence Bonham, discusses the skepticism the #SickelCell community feels regarding gene editing - https://t.co/koFIkOuUUC. Original paper - https://t.co/d3Y05KGaGt https://t.co/jWoa4eNxDK
RT @TicGene: Pour ajouter, au chapitre CRISPR, une étude (en anglais) sur les espoirs mais aussi les craintes des patients drépanocytaires,…
RT @GIMJournal: Patients, parents, and physicians express hopes and concerns over CRISPR-mediated genome editing for sickle cell disease #o…
RT @GIMJournal: Patients, parents, and physicians express hopes and concerns over CRISPR-mediated genome editing for sickle cell disease #o…
Pour ajouter, au chapitre CRISPR, une étude (en anglais) sur les espoirs mais aussi les craintes des patients drépanocytaires, leurs familles et leurs médecins. Une maladie que l'on pourrait peu être parvenir à guérir (et plus juste soigner).
Patients, parents, and physicians express hopes and concerns over CRISPR-mediated genome editing for sickle cell disease #openaccess https://t.co/r0fQFpxA1o https://t.co/1ZRVeBLt37
A CRISPR focus on attitudes and beliefs toward somatic genome editing from stakeholders within the sickle cell disease community https://t.co/KcUQMYyVM2
A #CRISPR focus on attitudes and beliefs toward somatic genome editing from stakeholders within the sickle cell disease community. Persaud A, Desine S, Blizinsky K, Bonham VL. Genet Med. 2018-12-24. https://t.co/4CL8F9BJw1
RT @MuinJKhoury: The advent of genome editing has renewed hope for the sickle cell disease community, but caution tempers this optimism. Ex…
RT @MuinJKhoury: The advent of genome editing has renewed hope for the sickle cell disease community, but caution tempers this optimism. Ex…
Open Access Paper from @nresearchnews Genetics in Medicine "A CRISPR focus on attitudes and beliefs toward somatic genome editing from stakeholders (patients, parents, & physicians) within the sickle cell disease community" https://t.co/WiD0u3otHt #SC
RT @MuinJKhoury: The advent of genome editing has renewed hope for the sickle cell disease community, but caution tempers this optimism. Ex…
The advent of genome editing has renewed hope for the sickle cell disease community, but caution tempers this optimism. Excellent @GIMJournal article on stakeholders’ perspectives. https://t.co/QjxlJDjyS1 https://t.co/onNvsUzXcn